Related Experiment Video
Updated: Jan 24, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Down-regulation of ERMN expression in relapsing remitting multiple sclerosis
Behnaz Salek Esfahani1, Jalal Gharesouran1,2, Soudeh Ghafouri-Fard2
1Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
Multiple Sclerosis (MS) is a chronic inflammatory disease causing demyelination and neurodegeneration in the central nervous system (CNS). Although the exact etiology of MS is still unclear, both genetic and environmental elements are regarded as causative factors. Environmental factors can induce a cascade of events in immune system leading to neuronal death and nerve demyelination. This paper aims to compare the peripheral transcript levels of Ermin (ERMN) (a gene with putative role in cytoskeletal rearrangements during myelinogenesis) and Listerin E3 Ubiquitin Protein Ligase 1 (LTN1) (a gene with functions in regulating innate immune system) between relapsing-remitting MS (RR-MS) patients and healthy controls. The results showed a significant decrease in ERMN expression (p = 0.022); whereas, no significant difference was detected in LTN1 expression between two groups (p = 0.935). The reduction in ERMN expression in leukocytes could be the cause of demyelinating process in RR-MS patients. Current findings might also have practical importance in prognosis and targeted therapies.
Insights
Multiple Sclerosis (MS) involves central nervous system demyelination. Researchers found reduced Ermin (ERMN) gene expression in relapsing-remitting MS patients, suggesting a role in the demyelinating process.
Area of Science:
- Neuroimmunology
- Molecular Biology
Background:
- Multiple Sclerosis (MS) is a chronic CNS inflammatory disease characterized by demyelination and neurodegeneration.
- The precise etiology of MS remains unknown, with both genetic and environmental factors implicated.
- Environmental triggers can initiate immune responses leading to neuronal damage and myelin loss.
Purpose of the Study:
- To investigate the peripheral transcript levels of Ermin (ERMN) and Listerin E3 Ubiquitin Protein Ligase 1 (LTN1) in relapsing-remitting MS (RR-MS) patients compared to healthy controls.
- To explore the potential roles of ERMN in myelinogenesis and LTN1 in innate immune regulation within the context of MS.
Main Methods:
- Peripheral blood leukocytes were collected from RR-MS patients and healthy controls.
- Quantitative analysis of ERMN and LTN1 gene expression levels was performed.
- Statistical analysis was used to compare gene expression between the two groups.
Main Results:
- A statistically significant decrease in ERMN expression was observed in RR-MS patients compared to controls (p=0.022).
- No significant difference in LTN1 expression was found between RR-MS patients and healthy controls (p=0.935).
Conclusions:
- Reduced ERMN expression in leukocytes may contribute to the demyelinating pathology observed in RR-MS.
- These findings suggest ERMN as a potential biomarker for MS prognosis and a target for novel therapeutic strategies.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Regulation of Expression at Multiple Steps
Constitutive and Regulated Gene Expression
Master Transcription Regulators
Epigenetic Regulation

